tiprankstipranks
Trending News
More News >
RegenXBio Inc. (RGNX)
:RGNX
US Market

RegenXBio (RGNX) Income Statement

Compare
912 Followers

RegenXBio Income Statement

Last quarter (Q4 2024), RegenXBio's total revenue was $21.21M, a decrease of -4.50% from the same quarter last year. In Q4, RegenXBio's net income was $-51.19M. See RegenXBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 83.33M$ 90.24M$ 112.72M$ 470.35M$ 154.57M
Gross Profit
$ 49.76M$ 53.03M$ 58.18M$ 418.51M$ 118.85M
Operating Expenses
$ 283.11M$ 321.16M$ 321.06M$ 258.53M$ 238.09M
Depreciation and Amortization
$ 16.21M$ 17.32M$ 12.91M$ 9.56M$ 8.41M
EBITDA
$ -198.23M$ -239.46M$ -244.24M$ 169.54M$ -96.83M
Operating Income
$ -233.35M$ -268.13M$ -262.88M$ 159.98M$ -119.23M
Other Income/Expenses
$ 6.24M$ 4.48M$ -17.53M$ -18.73M$ 13.22M
Pretax Income
$ -227.10M$ -263.65M$ -280.40M$ 141.25M$ -106.01M
Net Income
$ -227.10M$ -263.49M$ -280.32M$ 127.84M$ -111.25M
Per Share Metrics
Basic EPS
$ -4.59$ -6.02$ -6.50$ 3.01$ -2.98
Diluted EPS
$ -4.59$ -6.02$ -6.50$ 2.91$ -2.98
Weighted Average Shares Outstanding
49.51M 43.73M 43.15M 42.44M 37.28M
Weighted Average Shares Outstanding (Diluted)
49.51M 43.73M 43.15M 43.91M 37.28M
Currency in USD

RegenXBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis